Human papillomavirus infection in urine samples from male renal transplant patients

Journal of Medical Virology

Volumn 82, Issue 7, 2010, Pages 1179-1185

  Tornesello, Maria Lina ^a   Loquercio, Giovanna ^a   Tagliamonte, Maria ^a   Rossano, Fabio ^b   Buonaguro, Luigi ^a   Buonaguro, Franco Maria ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Human papillomavirus; Italy; Male; Renal transplant; Urine

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 12; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 20; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 71; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; URINALYSIS; VIRAL GENETICS; WART VIRUS; CLASSIFICATION; ISOLATION AND PURIFICATION; ITALY; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; URINE; VERY ELDERLY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

VIRUS DNA;

ADULT; AGED; AGED, 80 AND OVER; DNA, VIRAL; HUMANS; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS;

EID: 77954397494     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21784     Document Type: Article

References (41)

1. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F. 2003. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 89:1221-1227. (Pubitemid 37363407)
2. Aynaud O, Ionesco M, Barrasso R. 2003. Cytologic detection of human papillomavirus DNA in normal male urethral samples. Urology 61:1098-1101. (Pubitemid 36693977)
3. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El GF, Benbrahim- Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens - Part B: Biological agents. Lancet Oncol 10:321-322.
4. Brinkman JA, Rahmani MZ, Jones WE, Chaturvedi AK, Hagensee ME. 2004. Optimization of PCR based detection of human papillomavirus DNA from urine specimens. J Clin Virol 29:230-240.
5. Buonaguro FM, Tornesello ML, Beth-Giraldo E, Hatzakis A, Mueller N, Downing R, Biryamwaho B, Sempala SD, Giraldo G. 1996. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65:25-28. (Pubitemid 26027535)
6. Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah KV. 1997. Prevalence of penile human papilloma virus DNA in husbands of womenwith and without cervical neoplasia: A study in Spain and Colombia. J Infect Dis 176:353-361. (Pubitemid 27328757)
7. Costa FA, da Silva RC, Arruda LB, Duarte AJ, Casseb J. 2009. Prevalence of human papillomaviruses in urine samples of male patients infected with HIV-1 in Sao Paulo, Brazil. J Med Virol 81: 2007-2011.
8. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. 1995. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
9. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
10. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. 2006. Prevalence of HPV infection amongmen: Asystematic review of the literature. J Infect Dis 194:1044-1057.
11. Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf-Neto J, Shah KV, Snijders PJ, Meijer CJ, Bosch FX, Munoz N. 2002. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 86:705-711.
12. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, Markowitz LE, Smith D, Harris RB. 2007. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: The HPV detection in men study. J Infect Dis 196:1146-1152.
13. Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, Papenfuss MR, Abrahamsen M, Jolles E, Nielson CM, Baggio ML, Silva R, Quiterio M. 2008. The human papilloma virus infection in men study: Human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 17:2036-2043.
14. Golijow CD, Perez LO, Smith JS, Abba MC. 2005. Human papillomavirus DNA detection and typing in male urine samples from a high-risk population from Argentina. J Virol Methods 124:217-220.
15. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. 2007. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 370: 59-67.
16. Hernandez BY, McDuffie K, Goodman MT, Wilkens LR, Thompson P, Zhu X, Wong W, Ning L. 2006. Comparison of physician- and selfcollected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 44:513-517.
17. Jong E, van Gorp EC, Mulder JW, Tol A, Smits PH. 2009. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men. Int J STD AIDS 20:262-264.
18. Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Essahsah F, Fathers LM, Offringa R, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, van der Burg SH, Melief CJ. 2009. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 361:1838-1847.
19. Mahony JB, Luinstra KE, Tyndall M, Sellors JW, Krepel J, Chernesky M. 1995. Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary specimens. J Clin Microbiol 33:3049-3053.
20. Melief CJ, van der Burg SH. 2008. Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines. Nat Rev Cancer 8:351-360.
21. Munoz N, Castellsague X, Bosch FX, Tafur L, de Sanjose S, Aristizabal N, Ghaffari AM, Shah KV. 1996. Difficulty in elucidating the male role in cervical cancer in Columbia, a high-risk area for the disease. J Natl Cancer Inst 88:1068-1075.
22. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ,Meijer CJ. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med 348:518-527.
23. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. 2006. Chapter 1: HPV in the etiology of human cancer. Vaccine 24:S1-S10. (Pubitemid 44293019)
24. Munoz N, Manalastas R, Jr., Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A. 2009. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11 16, 18) recombinant vaccine in women aged 24-45 years: A randomised, double-blind trial. Lancet 373:1949-1957.
25. Nielson CM, Schiaffino MK, Dunne EF, Salemi JL, Giuliano AR. 2009. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis 199: 7-13.
26. Palefsky JM, Berry JM, Jay N, Krogstad M, Da CM, Darragh TM, Lee JY. 2006a. A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS 20: 1151-1155. (Pubitemid 43786103)
27. Palefsky JM, Gillison ML, Strickler HD. 2006b. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 24: 140-146. [Epub June 23, 2006].
28. Parkin DM, Bray F. 2006. Chapter 2: The burden of HPV-related cancers. Vaccine 24:S11-S25.
29. Quint WG, Pagliusi SR, Lelie N, de Villiers EM, Wheeler CM. 2006. Results of the first World Health Organization international collaborative study of detection of human papillomavirus DNA. J Clin Microbiol 44:571-579. (Pubitemid 43222253)
30. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, Manos MM. 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. JNatl Cancer Inst 82:1477-1484.
31. Rintala MA, Pollanen PP, Nikkanen VP, Grenman SE, Syrjanen SM. 2002. Human papillomavirus DNA is found in the vas deferens. J Infect Dis 185:1664-1667. (Pubitemid 34587531)
32. Schiffman M, Clifford G, Buonaguro FM. 2009. Classification of weakly carcinogenic human papillomavirus types: Addressing the limits of epidemiology at the borderline. Infect Agent Cancer 4:8.
33. Smits PH, Bakker R, Jong E, Mulder JW,Meenhorst PL, Kleter B, van Doorn LJ, Quint WG. 2005. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J Clin Microbiol 43:5936-5939. (Pubitemid 43100640)
34. Soderlund-Strand A, Carlson J, Dillner J. 2009. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J Clin Microbiol 47:541-546.
35. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD. 2003. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 95:1062-1071. (Pubitemid 36950110)
36. Tornesello ML, Duraturo ML, Botti G, Greggi S, Piccoli R, De Palo G, Montella M, Buonaguro L, Buonaguro FM. 2006. Prevalence of alpha-papillomavirus genotypes in cervical intraepithelial neoplasia and cervical cancer in the Italian population. J Med Virol 78: 1663-1672.
37. Tornesello ML, Duraturo ML, Buonaguro L, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. 2007. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer 2:1.
38. Tornesello ML, Duraturo ML, Giorgi-Rossi P, Sansone M, Piccoli R, Buonaguro L, Buonaguro FM. 2008a. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol 89:1380-1389.
39. Tornesello ML, Duraturo ML, Losito S, Botti G, Pilotti S, Stefanon B, Palo GD, Gallo A, Buonaguro L, Buonaguro FM. 2008b. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int J Cancer 122:132-137.
40. Veroux M, Corona D, Scalia G, Garozzo V, Gagliano M, Giuffrida G, Costanzo CM, Giaquinta A, Palermo I, Zappala D, Tallarita T, Zerbo D, Russo R, Cappellani A, Franchina C, Scriffignano V, Veroux P. 2009. Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: Preliminary data. Transplant Proc 41:1191-1194.
41. Weaver BA, Feng Q, Holmes KK, Kiviat N, Lee SK,Meyer C, Stern M, Koutsky LA. 2004. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 189:677-685.